Ammonium Chloride and Codeine Phosphate Oral Suspension, also known as Ammonium Chloride and Codeine Phosphate Mixture, is a medication commonly used to relieve cough symptoms in adults. However, it is not recommended for use in infants and young children due to the potential risks and side effects it may pose to their health.

One of the main concerns with giving Ammonium Chloride and Codeine Phosphate Mixture to babies is the risk of respiratory depression. Codeine, one of the active ingredients in the medication, can suppress the central nervous system and slow down breathing. In infants, who already have smaller airways and respiratory systems, this effect can be particularly dangerous and lead to serious complications such as difficulty breathing or even respiratory failure.

Additionally, codeine can also be metabolized into morphine in the body, especially in individuals with certain genetic variations. This can further increase the risk of respiratory depression and other side effects in babies who are given the medication.

Furthermore, Ammonium Chloride, another component of the mixture, can potentially cause acidosis in infants, leading to metabolic imbalances and other health issues.

Given these potential risks and the lack of sufficient evidence supporting the safety and efficacy of Ammonium Chloride and Codeine Phosphate Mixture in infants, it is crucial to avoid using this medication in babies unless specifically prescribed by a healthcare professional and under close supervision.

In conclusion, the use of Ammonium Chloride and Codeine Phosphate Mixture in babies can pose significant risks to their health, particularly in terms of respiratory depression and metabolic imbalances. It is important for parents and caregivers to consult with a healthcare provider before giving any medication to infants and to always follow their recommendations for safe and appropriate treatment options.